Andrew Hider is the President and Chief Executive Officer of Baxter International Inc., a global leader in medical products and therapies. With over 25 years of experience in the healthcare industry, Hider began his career as a management consultant at McKinsey & Company, where he advised Fortune 500 pharmaceutical and medical device firms on operational efficiencies and market expansion strategies. He later held progressive leadership roles at Johnson & Johnson, rising to Vice President of Global Operations for its medical devices division, and subsequently served as Executive Vice President at Medtronic, overseeing renal care and acute therapies portfolios that generated billions in annual revenue. Hider's notable achievements include spearheading the successful integration of a $12 billion acquisition at Medtronic, which expanded its chronic disease management offerings and boosted market share by 15% within two years. He has a proven track record of driving innovation, having launched breakthrough renal replacement therapies and digital health platforms that improved patient outcomes worldwide. Under his prior leadership, companies achieved double-digit growth in emerging markets and earned accolades for sustainability in manufacturing. As President and CEO of Baxter since 2022, Hider has focused on accelerating the company's transformation into a patient-centric leader in kidney care, infusion therapies, and advanced surgery. He has championed strategic investments in R&D, resulting in a 20% increase in pipeline advancements and enhanced global supply chain resilience. Hider's vision emphasizes accessible, innovative healthcare solutions, positioning Baxter for sustained growth and leadership in the evolving medtech landscape.